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Abstract
Genome-wide associations have shown a lot of promise in dissecting the genetics of complex traits in humans with single
variants, yet a large fraction of the genetic effects is still unaccounted for. Analyzing genetic interactions between variants
(epistasis) is one of the potential ways forward. We investigated the abundance and functional impact of a specific type of
epistasis, namely the interaction between regulatory and protein-coding variants. Using genotype and gene expression data
from the 210 unrelated individuals of the original four HapMap populations, we have explored the combined effects of
regulatory and protein-coding single nucleotide polymorphisms (SNPs). We predict that about 18% (1,502 out of 8,233
nsSNPs) of protein-coding variants are differentially expressed among individuals and demonstrate that regulatory variants
can modify the functional effect of a coding variant in cis. Furthermore, we show that such interactions in cis can affect the
expression of downstream targets of the gene containing the protein-coding SNP. In this way, a cis interaction between
regulatory and protein-coding variants has a trans impact on gene expression. Given the abundance of both types of
variants in human populations, we propose that joint consideration of regulatory and protein-coding variants may reveal
additional genetic effects underlying complex traits and disease and may shed light on causes of differential penetrance of
known disease variants.
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Introduction
Most disease association studies to date attempt to link single
genetic variants to a specific phenotype [1,2,3,4]. The genetic
interaction between variants, also called epistasis, results in a
phenotypic effect that is conditional on the combined presence of
two or more variants [5,6]. The prevalence and biological
significance of epistasis has always been an area of interest in
the field of human genetics and quantitative genetics, but its
contribution to phenotypic variation has remained obscure, largely
because genetic interactions have proven difficult to test [7]. This
difficulty arises primarily because it is unclear which variant
combinations should be tested and under which model of epistasis.
To date, most strategies that address the effects of epistasis in
humans involve millions of agnostic pairwise tests and fall into two
broad categories: exhaustive testing of interactions between all
pairs of variants across the genome [8], or testing of interactions
between all pairs of those variants that each have an independent
main effect on the phenotype of interest [8,9,10]. It is not entirely
clear whether improvements in statistical methods will be sufficient
to address the problem of epistasis. Therefore, the development of
realistic biological models of epistatic interactions may reduce the
statistical cost of dealing with many comparisons and facilitate the
development of such methodologies.
To date, such an approach has been most feasible in model
organisms and for specific genes or biological pathways that have
been well-characterised. One classic example is the Adh locus in
Drosophila where a series of regulatory SNPs in complex linkage
disequilibrium (LD) modify the effects of a protein-coding variant
[11,12]. The protein-coding variant affects the catalytic efficiency of
the ADHprotein,whereasthe regulatoryvariantshavean impacton
protein concentration. Catalytic efficiency and protein levels affect
the overall activity of ADH showing that large effects attributed to a
single locus may arise as a consequence of multiple associated
variants. More recent studies in Drosophila reveal epistatic effects
between genes affecting traits such as ovariole number [13] and
olfactory avoidance [14]. In cases where little is known about the
genes sculpting a phenotype, addressing the possibility of epistasis
becomes more challenging. The value of assessing the impact of
genetic interactions is highlighted in a recent study interrogating
cardiac dysfunction in Drosophila [15]. A major susceptibility locus
for this trait has been detected, but the importance of examining the
phenotype in different genetic backgrounds was highlighted as a
means to detect variants contributing to the phenotype through
interactions with the prime susceptibility locus. The extent of
epistasis in a more global way has been demonstrated in yeast where
experiments on gene expression revealed that interacting locus pairs
are involved in the inheritance of over half of all transcripts[5].
Furthermore, a large proportion of the eQTLs attributable to
interaction effects were not detected by single locus tests. This
suggests that analysis of interaction effects in other systems is likely to
uncover additional associations.
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detected in instances where there are biological clues as to which
genes should be testedforinteraction.Epistasisbetweentwomultiple
sclerosis (MS) associated HLA-DR alleles was demonstrated by
Gregerson et al. [16] who showed that one allele modifies the T-cell
response activated by a second allele, through activation-induced
apoptosis contributing to a milderformof MS-like disease.Similarly,
Oprea et al. [17] demonstrated that a specific modifier effect is
protective against spinal muscular atrophy (SMA). SMA arises from
a homozygous deletion of SMN1, but some deletion homozygotes
escape the disease phenotype due to the modulating effects of
expression of PLS2. With the explosion of successful genome-wide
association studies over the past two years, the need to address
epistasis in a systematic, genome-wide approach is becoming
increasingly pressing. The case of MS clearly illustrates this: as with
most complex disorders, MS has a polygenic heritable component
characterised by underlying complex genetic architecture [18].
Association studies to date have met with modest success in
identifying MS-causing genes, and a large proportion of phenotypic
variation remains unexplained. The expectation is that this residual
variation arises at least in part, as a consequence of gene-gene
interactions. Finally, epistasis may mask and prevent replication of
otherwise real genetic effects due to differential fixation of variants
that modulate the primary disease variant and affect the degree of
penetrance of certain disease alleles.
In this study we propose a biological framework that could be
useful for global survey of epistatic (modifier) effects in humans,
which avoids exhaustive testing of agnostic pairs and involves
prioritisation of variants to be tested. Two types of functional
variants are common throughout the human genome and are
presentatappreciablefrequenciesinpopulations:regulatoryvariants
with an impact on the expression patterns and levels of genes
[19,20,21,22,23] and protein-coding nucleotide variants affecting
protein sequence [19,24]. To date, the effects of these variants have
been considered independently of each other. In this study we
perform an evaluation of the joint effects of regulatory and protein-
codingvariantsto genome-wide expression phenotypesinhumans in
order to highlight an underappreciated angle of functional variation.
Results
The Model of Epistasis
Our model brings together quantitative and qualitative
variation. A gene that has an identified cis regulatory variant is
differentially expressed among individuals of a population where
that variant is segregating [20,23]. If this gene also contains coding
variation, then, assuming that mRNA levels are indicative of
mature protein levels, the resulting protein products will not only
differ in quantity (expression level) but also in quality or type
(amino acid sequence) among individuals. Furthermore, depend-
ing on the historical rate of recombination between the regulatory
and the coding variants, different allelic combinations (haplotypes)
can arise on the two homologous chromosomes in a population.
Phasing, the arrangement of the alleles at each variant with respect
to one another, can differ between individuals in the population
(Figure 1) [25]. If this is the case, the epistasic effect arising from
these two variant types can be explored under a specific and
testable biological model.
Using this model as a main principle, we explored the degree to
which protein-coding variants can be modulated by cis-acting
regulatory variants in human populations. In a previous study [20]
we identified a set of SNPs (minor allele frequency (MAF)$0.05)
implicated in regulation of activity of genes in EBV-transformed
lymphoblastoid cell lines (LCLs) of the unrelated individuals of the
HapMap populations [26,27] (60 Caucasians of Northern and
Western European origin (CEU), 45 unrelated Chinese individuals
from Beijing University (CHB), 45 unrelated Japanese individuals
from Tokyo (JPT), and 60 Yoruba from Ibadan, Nigeria (YRI)).
LCLs represent one particular cell type and even though there
may be some effect arising from EBV transformation, it has been
demonstrated that genetic effects on gene expression , such as the
ones we describe below, are readily identifiable and mappable,
and replicate in independent population samples. We henceforth
refer to genetic variants associated with gene expression levels as
candidate regulatory SNPs (rSNPs) and regard them as proxies for
the linked functional variants that drive differential expression
levels of nearby genes. The protein-coding variants considered
under this model are non-synonymous SNPs (nsSNPs), i.e. variants
that give rise to an amino acid substitution in the protein product.
nsSNPs harboured in genes with varying expression levels are
hereon termed differentially expressed (DE).
Differentially Expressed nsSNPs
Two strategies were applied to detect DE nsSNPs in the
HapMap populations. The first strategy involved scanning genes
with known rSNPs [20] for nsSNPs. The aim was to identify
nsSNPs that are predicted to be DE as a consequence of a nearby
regulatory variant tagged by an identified rSNP. From the 606,
634, 679 and 742 genes with rSNPs previously identified [20] (0.01
permutation threshold and estimated false discovery rate
(FDR)=20%) in the CEU, CHB, JPT and YRI respectively, we
found 159, 168, 180 and 202 of these genes (union of 484)
containing 286, 304, 311 and 393 nsSNPs respectively (union of
909) (Table S1). We infer that these nsSNPs are DE as they reside
in genes with experimentally-derived varying expression levels.
This means that there are allelic effects on gene expression such
that, depending on the genotypes of the rSNP and nsSNP and on
the phasing of their alleles, one can make predictions about the
relative abundance of the two alleles of a transcript in the cell.
The second strategy for DE nsSNP discovery involved direct
association testing between nsSNP genotype and expression levels
of the gene in which the nsSNP resides. We performed the test for
each expressed gene harbouring at least one nsSNP. This strategy
Author Summary
The ultimate goal of genome-wide association studies
(GWAS) is to explain the proportion of variation in a
phenotypic trait that can be attributed to genetic factors.
The past two years have seen a plethora of successes in
this field, yet, for most traits, a large fraction of variation
remains unexplained. Epistasis, or interaction between
genetic variants, is a largely under-explored factor, which
may shed some light in this area. We use the HapMap
populations to investigate interactions between regulatory
and protein-coding variants and their impact on gene
expression. We show that if a specific protein-coding
variant has a functional impact, this can be modified by a
co-segregating regulatory variant (cis interaction). Further-
more, the authors demonstrate that such modification
effects between variants at one locus may affect the
expression of other genes in the cell in a trans manner. The
aim of this article is to present a framework though which
variation can be considered in the context of GWAS.
Viewing variation from this underappreciated angle may,
in some cases, provide an explanation for differential
penetrance of complex disease traits, but also for non-
replication of GWAS results that may arise as a conse-
quence of such interactions.
Cis Epistatic Effects
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variant. Depending on the strength of the regulatory effect, such
variants may or may have not been detected in our initial scan for
rSNPs. Relative distances between rSNPs and nsSNPs can vary, but
in the special case where this distance is short in genetic terms, the
two variants may be in LD [25]. Under these circumstances we
expect that the nsSNP itself will demonstrate some degree of
association with expression levels of the gene in which it resides. We
used standard methodologies described in Stranger et al. 2007 [20]
(see Methods) to test for genotype-expression associations in each
population and in three multiple-population sample panels: (a) all
four HapMap populations, (b) three populations (CEU-CHB-JPT),
and (c) two populations (CHB-JPT). The choice of these panels
represents a pooling strategy by which we sequentially remove
individuals of the most genetically distant population sample.
For the single-populations analysis, with significance evaluated
at the 0.01 significance threshold as determined by 10,000
permutations, we expect 56 nsSNPs and 34 genes to have at least
one significant association by chance. We detected 242, 276, 267
and 255 nsSNPs (union of 703; estimated FDR ,21%) with
significant associations to expression levels of the gene in which
they reside for the CEU, CHB, JPT and YRI populations
respectively. These associated nsSNPs correspond to 196, 226, 210
and 211 genes (union of 560; estimated FDR ,16%) (Table 1).
For the multiple-population analysis at the same significance
threshold (using conditional permutations that account for
population differentiation–see Methods), we detected 345, 362
and 417 nsSNPs (estimated FDR ,15%) for the four, three and
two population groups respectively, corresponding to 284, 296 and
320 significant genes (estimated FDR ,11%) (Table 1). Overall,
the multiple-population analysis yielded a total of 587 nsSNPs with
significant associations, corresponding to 461 genes. Taken
together, the association analyses indicate that 884 nsSNPs (688
genes) are associated with expression levels of the genes they are in,
suggesting that they are in LD with regulatory variants driving
their expression. In this specific case of association, the nsSNP
itself serves as a proxy to the regulatory variant. Therefore,
knowledge of associated nsSNP genotype for an individual enables
us to make a prediction about the relative abundance of the two
alleles of a transcript containing the nsSNP.
To summarize, two classes of DE nsSNPs were discovered: (a)
nsSNPs mapping in genes with a previously-identified rSNP (909
nsSNPs, considering nsSNPs of all frequencies) and (b) nsSNPs
showing a significant association with expression levels of the gene
they are in (884 nsSNPs, considering nsSNPs with MAF$0.05)
(Figure 2a & b). From a non-redundant total of 8233 nsSNPs
tested, we predict that 1502 of these (,18.2%) are DE. If mature
protein levels mirror on average transcript levels, which is a
reasonable biological hypothesis, then this high fraction has
important implications for the levels of protein diversity in the cell.
Linkage Disequilibrium between rSNPs and nsSNPs
Of the 884 DE nsSNPs discovered through association testing
(set b above), only 291 also possess a previously identified rSNP.
This suggests that rSNP detection in our previous study [20] was
conservative and that nsSNPs can act as tags of (markers for)
nearby, undiscovered regulatory variants. With this in mind, we
expect that LD between rSNP- nsSNP pairs in which the nsSNP
had a significant association (0.01 permutation threshold) with
gene expression, will be greater than LD between rSNP- nsSNP
pairs in which the nsSNP was not associated. To explore this, we
used data from the single population analysis, and compared the
distribution of r-squared values (a measure of LD) between the two
rSNP-nsSNP pair types. As expected, we found much higher LD
Figure 1. Illustration of a hypothetical epistatic interaction between a regulatory and a protein-coding variant. Two double
heterozygote individuals may be genotypically identical, but the phasing of alleles can be different and may result in very distinct phenotypes
between individuals. In one individual (i) the A allele of the rSNP drives high expression levels of the protein arising from the C allele of the nsSNP. In
another individual (ii) the G allele of the rSNP drives low expression levels of the protein arising from the C allele of the nsSNP. If the protein-coding
variant is functionally important then this can give rise to different means in the distribution of a complex trait phenotype as shown on the right.
doi:10.1371/journal.pgen.1000244.g001
Cis Epistatic Effects
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association (Mann-Whitney p,0.0001) (Figure 2c). This confirms
that in most cases, association of the nsSNP with gene expression
of its own gene is due to a regulatory variant that acts as proxy to
the identified rSNP.
Experimental Verification of Differentially Expressed
nsSNPs
So far we have used genotypic associations, not direct allele-
specific quantification (allele-specific expression; ASE), to derive
relative abundance estimates for transcripts of genes containing
nsSNPs. To experimentally verify the predictions of the association
tests (i.e. that the alleles of associated nsSNP are DE), we tested a
subset of nsSNPs for allele-specific expression [22,28] in
heterozygote CEU and YRI individuals. The initial experiment
included a total of 141 nsSNPs from category (b) of DE nsSNPs.
nsSNPs of this category provide a prediction of the relative
abundance of the two alleles as transcripts in the cell. The assay
performed was new and proved noisy. As a result it was possible to
confirm and analyze signals for 28 nsSNPs. For individuals
heterozygous for each nsSNP, we assigned relative expression of
the two alleles. We then compared the experimentally derived
relative abundance, by ASE, with the predictions of relative
abundance from the genotypic association test. We found that
predicted and experimentally-quantified relative expression of
alleles of nsSNPs were in agreement for 89% (16 out of 18) and
90% (9 out of 10) of nsSNPs tested in the CEU and the YRI
populations, respectively. This is in agreement with the FDR
estimated above. This strongly suggests that the relative abun-
dance of alternative coding transcripts can be inferred reliably by
genotypic associations.
Properties of Differentially Expressed nsSNPs
To assess the potential biological impact of DE nsSNPs we
compared three functional attributes of those amino acid
substitutions arising from DE nsSNPs and those arising from
non-DE nsSNPs (nsSNP MAF$0.05, to assess common nsSNP
consequences). We investigated: (1) the relative position of
substitution on the peptide, as different effects may arise
depending on whether the nsSNP is at the beginning or the end
of the peptide), (2) the resulting change in peptide hydrophobicity
which may alter the interactions of a protein [29], and (3) the
resulting change in Pfam score (a measure of amino acid profile in
each position of a protein domain)[30], which assesses the integrity
of protein domains that are evolutionary conserved and likely to
harbour important functions. In all cases the properties of DE
nsSNPs were not different from those of nonDE nsSNPs. Though
indirect and not comprehensive, this signal suggests that DE
nsSNPs may be a random subset of nsSNPs (Figure S1 a–c).
To assess how many DE nsSNPs have a known function, we
explored the OMIM database [31] and found that 71 (out of 1502)
DE nsSNPs have an OMIM entry (Table S2). DE nsSNPs were
found to map in genes with a role in cancer susceptibility (BRAC1
(+113705), BARD1 (+113705)), asthma and obesity (ADRB2
(+109690)), Crohn’s disease (DLG5 (*604090)), myokymia (KCNA1
(*176260)), diabetes (OAS1 (*164350)), chronic lymphatic leukae-
mia (P2RX7 (*602566)) emphysema and liver disease (P
I(+107400)), severe keratoderma (DSP (+125647)), and familial
hypercholesterolemia (ABCA1 (+600046)). In some cases the
functional role of the nsSNP remains unclear and the noise in
reported functional effects in OMIM is well-known and very
difficult to assess in a study such as the present, but there are
examples where specific effects have been attributed to nsSNPs.
Table 1. nsSNP and gene cis associations in single and multiple-population subsets.
0.01 permutation threshold
1 234
Population
significant
nsSNPs
CEU-CHB-JPT-YRI
multipop
CEU-CHB-JPT
multipop
CHB-JPT
multipop
Overlap
1&2
Overlap
1&3
Overlap
1&4
CEU 242 345 362 417 111 139 104
CHB 276 345 362 417 126 162 224
JPT 267 345 362 417 136 161 203
YRI 255 345 362 417 102 86 90
Nonredundant 703
4 populations 34
$2 populations 233
0.01 permutation threshold
1 234
Population
significant
genes
CEU-CHB-JPT-YRI
multipop
CEU-CHB-JPT
multipop
CHB-JPT
multipop
Overlap
1&2
Overlap
1&3
Overlap
1&4
CEU 196 284 296 320 99 117 87
CHB 226 284 296 320 109 129 183
JPT 210 284 296 320 114 125 156
YRI 211 284 296 320 87 77 82
Nonredundant 560
4 populations 31
$2 populations 196
doi:10.1371/journal.pgen.1000244.t001
Cis Epistatic Effects
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bonding patterns and alterthe peptide tertiarystructure; rs28933383
in KCNA1 causes a substitution in a highly conserved position of the
potassium channel and is predicted to impair neuronal repolariza-
tion; rs28937574 in P2RX7 is a loss of function mutation associated
with chronic lymphatic leukaemia; rs28931572 in PI entails a
replacement ofapolarforanon-polaraminoacidand ispredictedto
disrupt tertiary structure of the protein, and rs2230806 in ABCA1 is
associated with protection against coronary heart disease in familial
hypercholesterolemia. The modulation of such strong effects by cis
regulatory variation may increase the complexity and severity of
these biological effects.
Genetic Interaction between rSNP and nsSNP
Thus far we have presented indirect evidence for an interaction in
cis where the effect of an nsSNP is modulated by a co-segregating
regulatory variant tagged by an rSNP. Under such circumstances,
and ifthe genecontaining the nsSNP hasdownstream targets,thenit
is likely that the expression of downstream genes may also be
affected. In other words, apart from the modification effect observed
incis,wewantedtotestforthegenome-wideeffectsofthisinteraction
directly, in a statistical framework. To do this we carried out
ANOVA by testing the main effects of rSNPs and nsSNPs and their
interaction term (rSNP6nsSNP) on genome-wide gene expression
(trans effects). The rationale behind this approach is that if an rSNP-
nsSNP interaction is biologically relevant,its effectmay influence the
expression of downstream targets of the gene harbouring the rSNP-
nsSNP pair. The power to detect an interaction is maximized when
all combinations of genotypes are present, each at appreciable
frequencies in the population. To increase power of interaction
detection, we pooled rare homozygotes with heterozygotes into a
single genotypic category, creating a 262 table of genotypes. This
does not bias our statistic as shown by permutations below. We
performed this analysis in the CEU population sample as CHB and
JPT population samples were small (45 individuals) and the YRI
sample has generally shown low levels of trans effects in previous
Figure 2. Strategies applied to discover differentially expressed (DE) nsSNPs and linkage disequilibrium properties between rSNP-
nsSNP pairs. (A) Two approaches were employed to discover DE nsSNPs: nsSNPs mapping in genes with a known rSNP (i) and nsSNPs that were
associated with expression levels of the gene they map in (ii). In (ii) the presence of a cis-acting regulatory variant is implied. For some nsSNPs with a
significant association, an identified cis rSNPs also exists (iii). In all other cases the nsSNPs interrogated were not inferred to be DE (iv). (B) (i) 909
nsSNPs map in a gene with an identified rSNP; (ii) 884 nsSNPs were found to be associated with levels of gene expression of the gene they reside in;
(iii) the overlap between i and ii (nsSNPs with an identified rSNP that also showed a significant association) is 291 (iii). 6731 nsSNPs show no evidence
for DE. (C) The distribution of r-squared (a measure of LD) was compared between rSNP-nsSNP pairs in which the nsSNP showed a significant
association (at the 0.01 permutation threshold) and SNP pairs in which the nsSNP was not associated. As expected, r-squared values are much higher
in the first case, in which the nsSNP is thought to act as a tag of the functional regulatory variant nearby.
doi:10.1371/journal.pgen.1000244.g002
Cis Epistatic Effects
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LD (D9#0.5) and a MAF$0.1 for both SNPs, against genome-wide
expression. At the 0.001 nominal p-value threshold, we expect
roughly 331 significant associations (assuming a uniform distribution
of p-values) for the interaction term. We observe 412, which
corresponds to an estimated FDR of 80%. This is overall a weak
signal (see also Figure 3a), but signals at the tail of the distribution
appear to be real given the limited power of this analysis (Figure 3c, d).
To test for potential biases in the statistic used, we carried out
the same tests using permuted gene expression values (a single
permutation was done by maintaining the correlation structure of
gene expression data–see Methods) relative to the rSNP-nsSNP
genotypes. We explored the p-value distribution of the rSNP-
nsSNP interaction for observed and permuted data (Figure 3b) and
found an abundance of low p-values in the observed data. There
appears to be some degree of p-value inflation in the observed data
relative to the permuted data which is most likely due to
correlations in gene expression data. This however does not affect
the enrichment of p-values seen in the tails of the observed
distribution relative to expected distributions (uniform distribution
of p-values) or the p-value distributions derived from permuted
gene expression data. The permutation was not done in order to
assess significance thresholds but rather in order to assess the
enrichment of tests with low p-values in the observed data and is in
agreement with the enrichment derived from the enrichment
under a uniform distribution of p-values. To further evaluate the
robustness of the interactions, we repeated the analysis for the top
10 rSNP-nsSNP significant pairs against their corresponding trans-
associated gene expression phenotype, after permuting rSNP
genotypes relative to nsSNP genotypes and gene expression values.
As expected, the significance of the interaction vanishes in the
permuted data. The conditional effects of alleles at the rSNP and
nsSNP loci can therefore have a very different impact on the
expression of other genes in the cell. This conditional effect on gene
expression is illustrated in Figures 3 c and d which show two
examples of an rSNP-nsSNP interaction (p=4.5610
211 and
p=2.2610
25), and in Table 2 where the summary statistics and
specificinformation ofSNPsandgenes areillustrated for the 10most
significant interaction effects. These plots illustrate the effect on gene
expression of different rSNP-nsSNP genotypic combinations. In
Figure 3c for example, SNP rs3009034 has an effect on gene
expression of gene NDN only if the genotype of SNP rs13093220 is
homozygous for the common allele. The phenotypic effect of such
interactions is even more prominent in Figure 3d where we observe
opposite directions of the effect of SNP rs1704196 on gene RLF
depending on the genotype on SNP rs6776417.
Figure 3. Impact of rSNP-nsSNP genetic interaction on trans gene expression. (A) QQ plot of observed –log10pvalues of the interaction term
in the ANOVA over expected (under the assumption of a Uniform distribution of p-values). (B) QQ plot of observed –log10pvalues of the interaction
term in the ANOVA over the –log10pvalues of the interaction term in the permuted data. (C) Example 1: The interaction between rs13093220 (rSNP)
and rs3009034 (nsSNP) on chromosome 3, is associated with changes in expression of NDN (probe ID GI_10800414-S) on chromosome 15 (interaction
p=4.5*10
211). (D) Example 2: The interaction between rs6776417 (rSNP) rs17040196 (nsSNP) on chromosome 3 is associated with changes in
expression of RLF (probe ID GI_6912631-S) on chromosome 1 (interaction p=2.2*10
25).
doi:10.1371/journal.pgen.1000244.g003
Cis Epistatic Effects
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We have presented a biological framework to interrogate
functional genetic variation by focusing on a specific case of
epistasis between regulatory and protein-coding variants. We have
shown that regulatory variants may have an impact on the protein
diversity of cells by differentially modulating the expression of
protein-coding variants. In cis, regulatory variants can amplify or
mask the functional effects of protein-coding variants, which
might consequently result in a milder or more severe phenotype
to the one expected if only the protein-coding variant were
present. We have shown that such interactions can affect the
expression of other genes in the cell (trans effect), in a manner that
can only be revealed if the interaction term of the two variants is
considered.
The conditional effects of alleles of functional variants may
therefore have important consequences for complex phenotypic
traits. The extent to which epistasis affects phenotypes remains an
under-explored area, but the critical importance of such
interactions is starting to emerge [17]. We provide a biological
framework for considering and conditioning existing disease
associations on known regulatory and protein-coding variants, in
an approach that also provides a potential explanation for the
differential penetrance of known disease variants. The abundance
of cis regulatory and protein-coding variants in human populations
and the generic nature of this type of epistatic interaction (no
assumptions about specific biological pathways) makes it very likely
that such interactions are common genetic factors underlying
complex traits and their consideration is likely to reveal important
associations that have not been detected thus far. Furthermore,
this consideration is particularly important for studies that fail to
replicate the primary disease associations in newly tested
populations, since it is hypothesized that some of the failures are
due to differential frequency of modifier alleles between the first
and second population. The consideration of the interactions
described above may assist in better interpretation of non-
replicated signals.
Methods
Gene Expression Quantification and Normalization
Total RNA was extracted from lymphoblastoid cell lines of the
210 unrelated individuals of the HapMap [26,27] (Coriell,
Camden, New Jersey, United States). Gene expression (mRNA
levels) was quantified using Illumina’s commercial whole genome
expression array, Sentrix Human-6 Expression BeadChip version
1( ,48,000 transcripts interrogated; Illumina, San Diego,
California, United States) [32]. Hybridization intensity values
were normalized on a log2 scale using a quantile normalization
method [33] across all replicates of a single individual followed by
a median normalization method across all 210 individuals. A
subset of 14,456 probes (13,643 unique autosomal genes) that were
highly variable within and between populations was selected from
the 47,294 probes on the array, and were used for the analysis. A
detailed description can be found in Stranger et al.[20].
Nonsynonymous (nsSNPs) and Regulatory (rSNPs) SNPs
HapMap nsSNPs (version 21, NCBI Build 35) were mapped
onto Refseq genes using nsSNP and gene coordinate information.
rSNPs are defined as those phase II HapMap SNPs (version 21,
NCBI Build 35, minor allele frequency (MAF)$0.05) with a cis
significant association at the 0.01 permutation threshold, as
described in Stranger et al. [20]. The genomic location of rSNPs
is within 1 Mb from the probe genomic midpoint.
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We tested nsSNP genotype for association with expression levels
of the gene it is in using an additive linear regression model
[3,20,34] applied to each population separately. Our association
analysis employed: 1) nsSNP genotypes for the unrelated
individuals of each HapMap population (MAF$0.05) from the
HapMap phase II map for each population (version 21, NCBI
Build 35) and 2) normalized log2 quantitative gene expression
measurements for the 210 unrelated individuals of each of the
original four HapMap populations (60 Caucasians of Northern
and Western European origin (CEU), 45 unrelated Chinese
individuals from Beijing University (CHB), 45 unrelated Japanese
individuals from Tokyo (JPT), and 60 Yoruba from Ibadan,
Nigeria (YRI)).
nsSNP Association and Multiple-Test Correction
Single Population Analysis
To assess significance of association between nsSNP genotype
and expression variation of the gene harbouring the nsSNP, we
performed 10,000 permutations of each expression phenotype
relative to the genotypes [20]. An association to gene expression
was considered significant if the nominal p-value from the linear
regression test was lower than the 0.01 tail of the distribution of the
minimal p-values (among all comparisons for a given gene) from
each of the 10,000 permutations of the expression phenotypes. For
genes containing more than one nsSNP the most stringent
permuted p-value was retained.
Multiple Population Panels
To increase the power of the nsSNP association analysis we
combined data (nsSNP genotypes and normalized expression values)
for unrelated individuals of multiple populations [20]. We compiled
three different multiple population comparison panels: 1) CEU-
CHB-JPT-YRI, 2) CEU-CHB-JPT, 3) CHB-JPT. Association tests
were carried out for each population panel separately using linear
regression. Conditional permutations (randomization of data within
each population as described in Stranger et al. [20]were performed
to assess significance of the nominal p-values. This approach
accounts for the population differentiation and prevents detection of
spurious associations [20]. For each of the 14,456 probes in each
multiple population panel, expression values were permuted among
individuals of a single population followed by regression analysis of
the grouped multi-population expression data against the grouped
multi-population permuted nsSNP genotypes. Associations were
considered significant if the nominal p-value was lower than the
threshold of the 0.01 tail of the distribution of the minimal p-values
from the 10,000 permutations of the expression phenotypes. For
genes containing more than one nsSNP the most stringent permuted
p-value was retained. It is important to note that in all cases
permutations maintained the correlated structure of gene expression
values (i.e. all gene expression values were randomized as a block for
each individual).
DNA and RNA Preparation for Allele-Specific Expression
(ASE) Assay
Genomic DNA (gDNA) and total RNA were extracted from
lymphoblastoid cell lines of the unrelated CEU and YRI HapMap
individuals (Coriell, Camden, New Jersey, United States) using
Qiagen’s AllPrep kit. RNA was treated with Turbo DNA-free
(Ambion) to minimize gDNA contamination. The RNA was
concentrated and further cleaned with RNeasy MinElute columns
(Qiagen). Total RNA and gDNA were quantified using Nanodrop
Spectrophotometer and either Quant-iT RNA or DNA reagents
(Invitrogen). Double stranded (ds) cDNA was synthesised from
250 ng of cleaned RNA. The first strand was synthesised with
Superscript III (Invitrogen) and random hexamers. The second
strand was synthesised with DNA polymerase I (Invitrogen),
ribonuclease H (Invitrogen) and dNTPs. The 96-well plate
containing the ds cDNA samples was cleaned using Multiscreen
PCR plate (Millipore).
Illumina ASE Array
The Oligo Pool All (OPA) was custom made by illumina and is
based on the Golden Gate assay. Only exonic SNPs$45 bp from
both exon edges were chosen for submission to illumina for assay
design to ensure that the assay would work equally well for
genomic and cDNA. SNPs that failed according to illumina’s
design scores were discarded. Paired ds cDNA and gDNA were
dried down in 96-well plates and re-suspended in 5 ml of HPLC
purified water. Golden Gate assays were then run for all samples
using the manufacturer’s standard protocol for gDNA (i.e. ds
cDNA was treated exactly the same way as gDNA). Reactions
were hybridised to 8612 Sentrix Array Matrix (SAM) Universal
Probe Sets so that 96 arrays could be run in parallel. Each bead
type (probe) is present on a single array on average 30 times. All
reactions were run in duplicate, so that each cell line had two ds
cDNA replicate and two gDNA replicate hybridizations. SAMs
were scanned with a Bead Station (illumina). A total of 1536 assays
were interrogated on the array but only 141 were nsSNPs from
this study and only 28 were selected based on data quality for
further analysis.
ASE Assay Data Pre-Processing
Data from each array was summarised by calculating the per
bead type average of 4 quantities after outlier removal: the
log2(Cy3) and log2(Cy5) intensities, average log-intensities
(
1/2log2(Cy5.Cy3)) and log-ratios (log2(Cy5/Cy3)). Outliers were
beads with values more than 3 median absolute deviations from
the median. Arrays with low dynamic range (determined using an
inter-quartile range cut-off of less than 1 for either the log2(Cy3) or
log2(Cy5) summary intensities) were discarded. The summarised
data was normalized by median centering the log-ratios. All
analysis was carried out in R using the beadarray package [35].
Direction of expression (high/low) was assigned to alleles for
nsSNPs fulfilling threshold criteria from the association study
(adjusted r
2 value$0.27; i.e. the nsSNP explained at least 27% of
the variance in gene expression of the gene it is found in so the
effect is expected to be large) and the ASE assay (average cDNA
log-intensity$12 within a population).
Assignment of Differentially Expressed (DE) nsSNPs
In each population an nsSNP is defined to be DE if: 1) it maps
within a gene that also has an independently identified cis rSNP or
2) it shows a significant association with its own gene’s expression
levels. We tested those rSNPs with the strongest association per
gene with nsSNPs of all frequencies. The total number of nsSNPs
that are predicted to be DE is the non-redundant union of 1)
and 2).
rSNP-nsSNP Pair Linkage Disequilibrium (LD) Analysis
LD values (r-squared and D9) were calculated by a pairwise
estimation between rSNPs and nsSNPs genotyped in the same
individuals and within a 100 kb window (Ensembl version 46). LD
estimates for rSNP-nsSNP pairs with and without an associated
nsSNP (0.01 permutation threshold) were compared using a
Mann-Whitney U test.
Cis Epistatic Effects
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Given that nsSNPs are likely to be functional we explored three
aspects of the resulting amino acid substitution: 1) Relative
position of substitution on the peptide, as a percent of peptide total
length. 2) Hydrophobicity change in peptide resulting from the
amino acid substitution. For each pair of variant sequences the
hydrophobicity at the position of the variant amino acid was
calculated using the Kyte-Doolittle algorithm using a window size
of 7 (centred on the variant amino acid). The difference between
hydrophobicty scores was then taken for each of the variant pairs
in the dataset. 3) Pfam score change in peptide sequence resulting
from the amino acid substitution. All sequences were searched
against the profile-HMM library provided by the Pfam database
(release 22.0) using hmmpfam from the HMMer software package
(version 2.3.2, http://hmmer.janelia.org/) and a default cut off E-
value of 10. Only the HMM_ls library was used so that domain
assignments to a pair of variant sequences were comparable. The
set of Pfam domain assignments were then filtered such that only
the domains that overlapped with the SNP position and that at
least one of the domain assignments from a pair of variant
sequences scored above the Pfam defined gathering threshold,
were considered in the subsequent analysis. The difference
between the two E-values was then taken for each of the variant
pairs in the dataset.
Trans Association Analysis
Our aim was to test the interaction effects of rSNP with nsSNP
on expression phenotypes in trans in the CEU population Our
strategy involved pooling the minor allele homozygote and the
heterozygote into a single genotypic category and then coding
genotypes as 0 (major allele homozygote) or 1 (heterozygote and
minor allele homozygote) for both SNP types. As a result four
possible rSNP-nsSNP genotypic combinations were possible: 0-0,
1-0, 0-1, 1-1. We performed ANOVA to test the effects of the
rSNP, the nsSNP, and the interaction term (rSNP6nsSNP) in the
same model against gene expression phenotypes in trans (in each
case excluding the gene from which the rSNP-nsSNP pair
originates). Tests were carried out for 22 SNP pairs with low LD
(D9#0.5) between the rSNP and the nsSNP and a MAF$0.1 for
both variants (to avoid outlier effects).
To assess significance of the interaction p-values we generated a
single permuted dataset of expression values relative to the
combined genotypes and compared the p-value distribution of the
interaction term for the observed and the permuted data. To
further evaluate the robustness of the observed interactions we
permuted the rSNP genotypes relative to nsSNP genotypes and
gene expression phenotypes, and re-ran the ANOVA association
test for the top 10 most significant interactions.
Supporting Information
Figure S1 We compared three functional attributes between
amino acid substitutions arising from differentially expressed (DE)
nsSNPs and those arising from non-DE nsSNPs. We investigated:
(A) the relative position of substitution on the peptide, (B) the
resulting change in peptide hydrophobicity [29] and (C) the
resulting change in Pfam score when searched against the Pfam
profile Hidden Markov Model library [30]. We conclude that DE
nsSNPs appear to be a random subset of nsSNPs. Therefore, if a
random nsSNP has a phenotypic effect, this is likely to be
amplified or masked through differential expression caused by a
cis-acting regulatory variant.
Found at: doi:10.1371/journal.pgen.1000244.s001 (0.91 MB TIF)
Table S1 nsSNPs and genes interrogated for differential
expression.
Found at: doi:10.1371/journal.pgen.1000244.s002 (0.01 MB PDF)
Table S2 Differentially expressed nsSNPs in OMIM.
Found at: doi:10.1371/journal.pgen.1000244.s003 (0.02 MB PDF)
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